Nørgaard M A, Andersen C B, Pettersson G
Department of Cardiothoracic Surgery, The National University Hospital, Rigshospitalet, Copenhagen, Denmark.
Eur J Cardiothorac Surg. 1998 Sep;14(3):311-8. doi: 10.1016/s1010-7940(98)00182-1.
To study the frequency of histological obliterative bronchiolitis and clinical bronchiolitis obliterans syndrome after en bloc double lung transplantation with bronchial artery revascularization and bilateral lung transplantation without bronchial artery revascularization.
Primary en bloc double lung transplantation with bronchial artery revascularization using the internal mammary artery as conduit was performed in 62 patients. The frequencies of obliterative bronchiolitis and bronchiolitis obliterans syndrome have been established from transbronchial biopsies and lung function measurements. Results have been analyzed in relation to the arteriographic success of bronchial artery revascularization and have been compared to results from Stanford University, obtained through personal communications.
Survival after 1, 2, 3, 4 and 5 years was 85, 81, 69, 69, and 69%, respectively. Fifteen patients developed bronchiolitis obliterans syndrome while seven developed obliterative bronchiolitis. Survival was superior for patients with bronchial artery revascularization classified as complete or incomplete bilateral versus incomplete hemilateral, incomplete poor or failed (P = 0.016, log-rank test). For patients surviving > or = 3 months post-transplant, the post-operative baseline FEV1 was lower for patients who later developed bronchiolitis obliterans syndrome compared to patients who did not (P = 0.007). The development of bronchiolitis obliterans syndrome and obliterative bronchiolitis were both correlated to observation time post-transplant but not to the number of rejections or infections when corrected for observation time.
In a subgroup of lung transplant patients, a process in the transplanted lungs, eventually leading to bronchiolitis obliterans syndrome diagnosis, seems to start in the donor during the transplantation and/or in the early post-operative cause. A comparison with results after bilateral lung transplantation without bronchial artery revascularization suggests that good direct bronchial artery revascularization may postpone the onset of bronchiolitis obliterans syndrome and obliterative bronchiolitis. The positive trend motivates further use of direct bronchial artery revascularization in lung transplantation.
研究采用支气管动脉血运重建的整块双肺移植和未进行支气管动脉血运重建的双侧肺移植后组织学闭塞性细支气管炎及临床闭塞性细支气管炎综合征的发生率。
62例患者采用以胸廓内动脉为导管的支气管动脉血运重建进行原发性整块双肺移植。通过经支气管活检和肺功能测量确定闭塞性细支气管炎和闭塞性细支气管炎综合征的发生率。分析结果与支气管动脉血运重建的血管造影成功情况的关系,并与通过个人交流获得的斯坦福大学的结果进行比较。
1年、2年、3年、4年和5年的生存率分别为85%、81%、69%、69%和69%。15例患者发生闭塞性细支气管炎综合征,7例发生闭塞性细支气管炎。与完全或不完全双侧支气管动脉血运重建相比,不完全单侧、不完全不良或失败的支气管动脉血运重建患者的生存率更高(P = 0.016,对数秩检验)。对于移植后存活≥3个月的患者,与未发生闭塞性细支气管炎综合征的患者相比,后来发生该综合征的患者术后基线第一秒用力呼气量(FEV1)更低(P = 0.007)。闭塞性细支气管炎综合征和闭塞性细支气管炎的发生均与移植后的观察时间相关,但在校正观察时间后与排斥反应或感染的次数无关。
在一部分肺移植患者中,移植肺中的一个过程最终导致闭塞性细支气管炎综合征的诊断,这个过程似乎在移植期间的供体中以及/或者术后早期就开始了。与未进行支气管动脉血运重建的双侧肺移植结果相比,良好的直接支气管动脉血运重建可能会推迟闭塞性细支气管炎综合征和闭塞性细支气管炎的发病。这种积极趋势促使在肺移植中进一步使用直接支气管动脉血运重建。